Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy

Published:2019-08 Issue: Volume:94 Page:82-96
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Tran Tuan Hiep,Tran Thi Thu Phuong,Truong Duy Hieu,Nguyen Hanh Thuy,Pham Tung Thanh,Yong Chul Soon,Kim Jong Oh

Funder

Medical Research Center Program

Yeungnam University

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference133 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. The promise and challenges of car-t gene therapy;Kuehn;JAMA,2017

3. Toll-like receptor agonists in cancer therapy;Adams;Immunotherapy,2009

4. Engineered T cells: the promise and challenges of cancer immunotherapy;Fesnak;Nat. Rev. Cancer,2016

5. Advantages and clinical applications of natural killer cells in cancer immunotherapy;Ames;Cancer Immunol. Immunother.,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination;Journal of Controlled Release;2024-10

2. Network Pharmacology Combined with GEO Analysis of the Mechanism of Qing-Jin-Hua-Tan Decoction in the Treatment of Non-small Cell Lung Cancer;Current Computer-Aided Drug Design;2024-08

3. Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma;Frontiers in Immunology;2024-06-12

4. Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapies;Immunology Letters;2024-06

5. Protective Efficacy of a Novel DNA Vaccine with a CL264 Molecular Adjuvant against Toxoplasma gondii in a Murine Model;Vaccines;2024-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3